Saturday, 16th of April 2011 |
Full text, with figures, is at
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)62028-6/fulltext
Saad B Omer a b c , Girish S Hiremath d, Neal A Halsey e
With 279 000 reported cases and 197 000 deaths per year, measles continues to be an important cause of childhood morbidity and mortality, especially in low-income countries.1 In 2008, the World Health Assembly reaffirmed the goal to reduce mortality from measles by more than 90% in 2010, compared with rates from 2000.2 Moreover, WHO's executive board has instructed its organisation to explore the feasibility of global measles elimination. Programmatic and technological innovation will be needed to sustain recent successes in reduction of the global burden of measles.
Delivery of the measles vaccine through the respiratory tract could help this effort. Respiratory delivery generates robust local and systemic immune responses3, 4 and this route is better for boosting responses in seropositive people than are injectable vaccines.5 Furthermore, mucosal administration is less likely to be blocked by maternal antibodies in infants than is a subcutaneous measles vaccine.6 Administration of aerosol vaccines needs fewer skills than does administration of injectable vaccines. Furthermore, use of non-injectable vaccines reduces the likelihood of unsafe disposal and reuse of syringes in immunisation programmes.
The idea to use the respiratory tract for delivery of measles vaccine is not new. Sabin7 suggested use of aerosolised measles vaccines in mass campaigns, and contributed to the design of an early aerosol vaccine delivery device, generally known as the classic Mexican device. The device is a plastic nebuliser containing reconstituted vaccine that is placed in crushed ice, and a connected compressor that generates the aerosols. Early designs of this device had several limitations, including the need for crushed ice and electrical power to run the compressor, a poor understanding of the correct dose for different ages, and the potential for transmission of respiratory pathogens.
In our meta-analysis8 of 20 reported comparisons from 16 studies, we reported that measles vaccines delivered through the respiratory route were at least as immunogenic as the same vaccine delivered subcutaneously. In another meta-analysis by Low and co-workers,9 children aged 10—36 months who were given aerosolised measles vaccine had seroconversion rates similar to children in the same age-group who received the vaccine subcutaneously. In infants younger than 10 months and children aged 5—15 years, results of studies were heterogeneous; therefore, seroconversion data were not pooled in this meta-analysis.9 Neither of these meta-analyses presented pooled safety data because of the inconsistent definitions of adverse events that were used in individual studies. However, the studies did not report any substantial differences in rates of serious adverse events between recipients given measles vaccines through the respiratory route versus the subcutaneous route.8, 9
With improvements in vaccine-delivery technology and progress in overcoming shortcomings of early devices, interest in respiratory delivery of measles vaccines has increased in recent years. Several groups10 are investigating methods of respiratory delivery of measles vaccines, such as nasal sprays, dry powders, and jet and piezoelectric (or mesh) nebulisers. Some development activities are being coordinated by WHO's Measles Aerosol Project, which aims to license at least one respiratory method to deliver vaccines that are administered subcutaneously.10 Products developed through this process will be used for routine immunisation of children aged 12—59 months and for mass immunisation of those aged 9 months to 18 years.11 The WHO project is investigating at least three methods for delivery of reconstituted aerosol measles vaccine.10 A device that uses dry-powder vaccine might also be assessed. Clinical trials10 are underway in India and Mexico to investigate the immunogenicity and safety of vaccine delivered through these devices, and at least one of these devices might be ready to be licensed in India by 2011.
Full-size image (22K) Science Photo Library
Despite much progress towards a deployable and safe method to deliver aerosolised measles vaccine, substantial challenges remain. Assessment of safety is one such challenge—especially in some high-risk groups, including children with asthma and immunocompromised children, such as those with HIV. Although parents in many populations might prefer the respiratory route instead of the subcutaneous route of measles vaccine administration, the acceptability of aerosol vaccines cannot be taken for granted. For example, uptake rates of the intranasal influenza vaccine have been lower than were expected.12 Moreover, most assessments of aerosol measles vaccines have been based on immunogenicity-related endpoints with only a small amount of data about clinical effectiveness, mostly outbreak-related data from Mexico.13 Randomised trials with disease-related endpoints, or at least studies of post-licensure field effectiveness, will be needed to assess the use and safety of respiratory measles vaccines.
SBO has received an award from the National Foundation of Infectious Diseases; GSH declares that he has no conflicts of interest; and NAH has received grants from GlaxoSmithKline and Merck, honoraria from Merieux and the National Foundation for Infectious Diseases, a travel grant from Sanofi Pasteur, and has served on data and safety monitoring boards for Merck and Novartis. SBO's work on this Comment was in part supported by the Emory University, Global Health Institute Faculty of Distinction Fund award. We thank Deanna West-Tankoo for her help with administration and retrieving relevant articles.
References
1 Anon. Progress in global measles control and mortality reduction, 2000—2007. MMWR Morb Mortal Wkly Rep 2008; 57: 1303-1306. PubMed
2 WHO. Outcome of the sixty-first World Health Assembly resolution: global immunization strategy. http://apps.who.int/gb/ebwha/pdf_files/EB123/B123_2-en.pdf. (accessed Nov 8, 2009).
3 LiCalsi C, Maniaci MJ, Christensen T, Phillips E, Ward GH, Witham C. A powder formulation of measles vaccine for aerosol delivery. Vaccine 2001; 19: 2629-2636. CrossRef | PubMed
4 Sabin AB, Flores AA, de Fernandez CJ, et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine I: different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA 1983; 249: 2651-2662. PubMed
5 Bellanti JA, Zeligs BJ, Mendez-Inocencio J, et al. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. Vaccine 2004; 22: 1214-1220. CrossRef | PubMed
6 Khanum S, Garelick H, Uddin N, Mann G, Tomkins A. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet 1987; 1: 150-153. PubMed
7 Sabin AB. My last will and testament on rapid elimination and ultimate global eradication of poliomyelitis and measles. Pediatrics 1992; 90: 162-169. PubMed
8 Hiremath GS, Omer SB. A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration. Hum Vaccin 2005; 1: 30-36. PubMed
9 Low N, Kraemer S, Schneider M, Restrepo AM. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis. Vaccine 2008; 26: 383-398. CrossRef | PubMed
10 WHO. The Initiative for Vaccine Research: strategic plan 2006—2009. http://www.who.int/vaccines-documents/DocsPDF06/854.pdf. (accessed Nov 8, 2009).
11 WHO. Measles Aerosol Project. http://www.who.int/immunization_delivery/new_vaccines/technologies_aerosol/en/index.html. (accessed Nov 9, 2009).
12 Tosh PK, Boyce TG, Poland GA. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin Proc 2008; 83: 77-84. CrossRef | PubMed
13 Fernandez-de CJ, Kumate-Rodriguez J, Sepulveda J, Ramirez-Isunza JM, Valdespino-Gomez JL. Measles vaccination by the aerosol method in Mexico. Salud Publica Mex 1997; 39: 53-60. (in Spanish). PubMed
a Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA 30322, USA
b Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
c Emory Vaccine Center, Atlanta, GA, USA
d INOVA Fairfax Hospital for Children, Fairfax, VA, USA
e Department of International Health and Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Assessment of Immune Status Against Measles, Mum ...
Assessment of Immune Status Against Measles, Mumps, and Rubella in Young Kuwaitis: MMR Vaccine Efficacy. Madi N, Altawalah H, Alfouzan W ...2017 M&RI Partners Meeting Presentations
The global Measles and Rubella Initiative meeting was held in Washington DC on 7th and 8th Sept. 2017. The meeting which was hosted by American Red Cr ...STORIES OF LIFE IN A CHANGING WORLD Scientists Cr ...
STORIES OF LIFE IN A CHANGING WORLD Scientists Crack a 50-Year-Old Mystery about the Measles Vaccine Worth a little pain? Back in 1990 a school bo ...20 most consulted measles and rubella articles in ...
Dear AllToday we share a review of the year 2016 regarding measles and rubella items posted on our web page. We shared articles on topics ranging from ...Region of the Americas is declared free of measles ...
More information on this great milestone can be found on url link belowhttp://www.paho.org/hq/index.php?option=com_content&view=article&id=125 ...Progress Toward Regional Measles Elimination — W ...
Progress Toward Regional Measles Elimination — Worldwide, 2000–2014 Morbidity and Mortality Weekly Report Best read, with ta ...Health Equity Initiative, New York, NY, 25-26 Febr ...
Health Equity Initiative, Summit, NYC, 25-26 February 2016 For details, consult http://www.healthequityinitiative.org/hei/programs/summit/REQUEST FOR PROPOSAL: MEASLES VACCINATION UNDER 9 ...
1 REQUEST FOR PROPOSAL: Measles Vaccination Under 9 Months of Age APPLICATION SUBMISSION DATE: January 26, 2015 1. In ...CARTOON CHARACTERS JOIN THE FIGHT AGAINST MEASLES
[source] Measles and Rubella Initiative[|source]Thanks to reader Jane Wachira for pointing out the following weblink. Measles eradication consists not ...I LOVE/HATE THIS GLOBAL VACCINATION COVERAGE GRAPH ...
[source]Rosling s FactPod[|source]This video from Hans Rosling explaining what he loves with global measles vaccination coverage trends namely rapid i ...POWER POINT PRESENTATIONS FROM THE 13TH ANNUAL ADV ...
[source]Measles and Rubella Initiative[|source]The Measles and Rubella Initiative has spent much effort fighting for its cause by means of widespread ...CALLING THE SHOTS
[source]PBS Network[|source]"VACCINES -- CALLING THE SHOTS" This TV program, broadcast on the PBS network, looks at the commonest arguments by anti-v ...COMBATING HEALTHCARE CORRUPTION AND FRAUD WITH IMP ...
[source]BMC International Health and Human Rights[|source]Corruption is a serious threat to global health outcomes, leading to financial waste and adv ...CORRUPTION KILLS: ESTIMATING THE GLOBAL IMPACT OF ...
[source]PLoS One[|source]Many countries still have high levels of child mortality, particularly in sub-Saharan Africa and South Asia, and in recent ye ...READY OR NOT: RESPONDING TO MEASLES IN THE POSTELI ...
[source]Annals of Internal Medicine[|source]Opnion Paper Although endemic measles was eliminated in the United States in 2000, two concurrent measle ...RUBELLA AND CONGENITAL RUBELLA SYNDROME CONTROL AN ...
[source]Morbidity and Mortality Weekly Report (MMWR)[|source]In 2011, the World Health Organization (WHO) updated guidance on the preferred strategy f ...PROGRESS TOWARDS MEASLES ELIMINATION – EASTERN M ...
[source]Weekly Epidemiological Record (WER)[|source]During the period 2008–2012, regional progress towards measles elimination stagnated, and th ...THE IMMUNIZATION PROGRAMME THAT SAVED MILLIONS OF ...
[source]Bulletin of the WHO[|source]In the world vaccination week, the Bulletin of the World Health Organization outlines the history, status and impa ...HEALTH SYSTEM COST OF DELIVERING ROUTINE VACCINATI ...
[source]Bulletin of the WHO[|source]On the eve of the 40th anniversary of launching of the Expanded Programme on Immunization (EPI) in 1974, during th ...World Immunization Week
[source]WHO/IVB Publication[|source]Never miss another jab, The slogan for World Immunization Week 2014 is “Immunize for a healthy future: Know ...Measles: know the risks, check your status, protec ...
[source]WHO/IVB Publication[|source]Measles is a highly contagious, serious disease caused by a virus. In 1980, before widespread vaccination, measles ...THE RIGHTS OF THE UNVACCINATED CHILD: THE LEGAL FR ...
[source]Los Angeles Times[|source]In light of what s starting to look like a surge of measles cases spread by unvaccinated carriers, Hasting ...Consultants: Measles and rubella control/eliminati ...
[source]Technical Network for Strengthening EPI[|source]Announcement solicits interest from potential candidates to act as consultants for WHO through ...PUBLIC HEALTH OFFICIALS MARK 50TH YEAR OF MEASLES ...
[source]Journal of American Medical Association[|source]Until the 1960s, measles was a rite of passage for US children; nearly all had the disease bef ...THE TOLL OF THE ANTI-VACCINATION MOVEMENT, IN ONE ...
[source]Los Angelos Times[|source]Aaron Carroll today offers a graphic depiction of the toll of the anti-vaccination movement. It comes from a Council ...“Can we use $30 of the taxes you’re already pa ...
[source]Annual Letter of BMGF[|source]If you were asked this question today, what answer would you give? Bill and Melinda Gates ask, "Would you check ...REACHING HARD-TO-REACH INDIVIDUALS: NONSELECTIVE V ...
[source]American Journal of Epidemiology[|source]Source: American Journal of Epidemiology The World Health Organization guidelines for response to me ...Rubella and Congenital rubella syndrome control an ...
[source]Weekly Epidemiological Record (WER)[|source]Full text record of Rubella and CRS control/elimination are available at http://www.who.int/wer/20 ...Measles Press Conference at CDC: 50th Anniversary ...
[source]CDC Media Release, 5th Dec[|source]Full text, video and question and answer session for journalists all avalable at http://www.cdc.gov/media/r ...A bibliometric analysis of childhood immunization ...
[source]BMC Medicine[|source]During the past four decades national EPI programs have developed or adapted and implemented a broad range of strategies ...Lessons from the tragic measles outbreak in Samoa
Monday, 9th of March 2020 |
Characterisation of diversity of measles viruses in India: genomic sequencing and comparative genomics studies.
Monday, 9th of March 2020 |
The elimination of measles in Iran
Monday, 9th of March 2020 |
Measles-containing vaccines in Brazil: Coverage,
Monday, 9th of March 2020 |
Measles-containing vaccines in Brazil: Coverage, homogeneity of coverage and associations with contextual factors at municipal level.
Monday, 9th of March 2020 |
Website Views |
47362652 |